Cysteine derivatives
US3950387A · kind A · utility
15Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 7, 1973 |
| Grant date | Apr 13, 1976 |
| Priority date | — |
| Expiry date | Jun 7, 1993 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
S-substituted cysteines, alkyl esters of S-substituted cysteines and S-substituted glutathiones in which the substituent on the S atom is allyl, geranyl, cinnamyl, benzylidene-3-butyl, 1-(para-chlorophenyl)ethyl and (pyridyl-3)methyl but excluding S-allyl cysteine bring about a reduction in atheromatic deposits in the aorta of test animals as well as a reduction in hypercholesterolemia and are of low toxicity. They may be used by the conventional routes for the treatment of human atheromatic conditions and disorders of the lipid metabolism.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.